Education
About Us
Working with TipRanks
Follow Us
AFT Pharmaceuticals Ltd. (AU:AFP)
ASX:AFP
Total Valuation
AFT Pharmaceuticals Ltd. has a market cap or net worth of AU$327.36M. The enterprise value is AU$272.86M.
Market CapAU$327.36M
Enterprise ValueAU$272.86M
Share Statistics
AFT Pharmaceuticals Ltd. has 104,866,260 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding104,866,260
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
AFT Pharmaceuticals Ltd.’s return on equity (ROE) is 0.12 and return on invested capital (ROIC) is 6.48%.
Return on Equity (ROE)0.12
Return on Assets (ROA)0.07
Return on Invested Capital (ROIC)6.48%
Return on Capital Employed (ROCE)0.09
Revenue Per Employee1.87M
Profits Per Employee0.00
Employee Count110
Asset Turnover1.21
Inventory Turnover2.40
Valuation Ratios
The current PE Ratio of AFT Pharmaceuticals Ltd. is 20.7. AFT Pharmaceuticals Ltd.’s PEG ratio is ―.
PE Ratio20.7
PS Ratio0.00
PB Ratio0.00
Price to Fair Value2.72
Price to FCF0.00
Price to Operating Cash Flow25.94
PEG Ratio―
Income Statement
In the last 12 months, AFT Pharmaceuticals Ltd. had revenue of 205.49M and earned 11.96M in profits. Earnings per share was 0.11.
Revenue205.49M
Gross Profit89.19M
Operating Income11.70M
Pretax Income16.03M
Net Income11.96M
EBITDA21.52M
Earnings Per Share (EPS)0.11
Cash Flow
In the last 12 months, operating cash flow was 13.18M and capital expenditures -281.00K, giving a free cash flow of 12.89M billion.
Operating Cash Flow13.18M
Free Cash Flow12.89M
Free Cash Flow per Share0.12
Dividends & Yields
AFT Pharmaceuticals Ltd. pays an annual dividend of AU$0.017, resulting in a dividend yield of 0.53%
Dividend Per ShareAU$0.017
Dividend Yield0.53%
Payout Ratio11.34%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.29
52-Week Price Change22.83%
50-Day Moving Average2.82
200-Day Moving Average2.50
Relative Strength Index (RSI)58.11
Average Volume (3m)2.52K
Important Dates
AFT Pharmaceuticals Ltd. upcoming earnings date is May 25, 2026, After Close (Confirmed).
Last Earnings DateNov 19, 2025
Next Earnings DateMay 25, 2026
Ex-Dividend Date―
Financial Position
AFT Pharmaceuticals Ltd. as a current ratio of 2.50, with Debt / Equity ratio of 30.72%
Current Ratio2.50
Quick Ratio1.38
Debt to Market Cap0.10
Net Debt to EBITDA0.88
Interest Coverage Ratio4.15
Taxes
In the past 12 months, AFT Pharmaceuticals Ltd. has paid 4.63M in taxes.
Income Tax4.63M
Effective Tax Rate0.29
Enterprise Valuation
AFT Pharmaceuticals Ltd. EV to EBITDA ratio is 13.20, with an EV/FCF ratio of 45.64.
EV to Sales1.38
EV to EBITDA13.20
EV to Free Cash Flow45.64
EV to Operating Cash Flow21.56
Balance Sheet
AFT Pharmaceuticals Ltd. has AU$11.11M in cash and marketable securities with AU$30.00M in debt, giving a net cash position of -AU$18.89M billion.
Cash & Marketable SecuritiesAU$11.11M
Total DebtAU$30.00M
Net Cash-AU$18.89M
Net Cash Per Share-AU$0.18
Tangible Book Value Per ShareAU$0.37
Margins
Gross margin is 44.09%, with operating margin of 5.69%, and net profit margin of 5.82%.
Gross Margin44.09%
Operating Margin5.69%
Pretax Margin7.80%
Net Profit Margin5.82%
EBITDA Margin10.47%
EBIT Margin9.18%
Analyst Forecast
The average price target for AFT Pharmaceuticals Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target―
Price Target Upside―
Analyst ConsensusHold
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―